NCT05120232View on ClinicalTrials.gov

Flourishing and Virtue in Cognitive-Behavioral Therapy for Anxiety and Depressive Disorders

NACompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

March 8, 2021

Primary Completion Date

July 1, 2023

Study Completion Date

January 16, 2024

Conditions
Anxiety DisordersDepressive Disorder
Interventions
BEHAVIORAL

Unified Protocol

A transdiagnostic, cognitive behavioral therapy.

BEHAVIORAL

Modified Unified Protocol (UP+)

A transdiagnostic, cognitive behavioral therapy.

Trial Locations (1)

02115

Center for Anxiety and Related Disorders - Boston University, Boston

All Listed Sponsors
collaborator

University of Kentucky

OTHER

collaborator

Harvard School of Public Health (HSPH)

OTHER

lead

Boston University Charles River Campus

OTHER

NCT05120232 - Flourishing and Virtue in Cognitive-Behavioral Therapy for Anxiety and Depressive Disorders | Biotech Hunter | Biotech Hunter